[{"address1": "P.O. Box 134", "city": "Malvern", "state": "PA", "zip": "19355", "country": "United States", "phone": "610 725 1500", "website": "https://www.galeratx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Galera Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule dismutase mimetic for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC); for the treatment of radiotherapy-induced esophagitis in patients with lung cancer; and for patients with HNC undergoing standard-of-care radiotherapy. It also develops rucosopasem manganese (rucosopasem) to augment the anti-cancer efficacy of stereotactic body radiation therapy in patients with non-small cell lung cancer and locally advanced pancreatic cancer. The company was incorporated in 2012 and is based in Malvern, Pennsylvania.", "fullTimeEmployees": 7, "auditRisk": 9, "boardRisk": 8, "compensationRisk": 8, "shareHolderRightsRisk": 7, "overallRisk": 8, "governanceEpochDate": 1717200000, "maxAge": 86400, "priceHint": 4, "previousClose": 0.083, "open": 0.09, "dayLow": 0.075, "dayHigh": 0.0998, "regularMarketPreviousClose": 0.083, "regularMarketOpen": 0.09, "regularMarketDayLow": 0.075, "regularMarketDayHigh": 0.0998, "beta": 2.042, "forwardPE": -0.06774193, "volume": 866771, "regularMarketVolume": 866771, "averageVolume": 1897314, "averageVolume10days": 669660, "averageDailyVolume10Day": 669660, "bid": 0.0782, "ask": 0.1022, "marketCap": 4568944, "fiftyTwoWeekLow": 0.065, "fiftyTwoWeekHigh": 3.195, "fiftyDayAverage": 0.16254, "twoHundredDayAverage": 0.173155, "currency": "USD", "enterpriseValue": 143392144, "floatShares": 36237151, "sharesOutstanding": 54392200, "sharesShort": 2123783, "sharesShortPriorMonth": 2657537, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.039, "heldPercentInsiders": 0.36153, "heldPercentInstitutions": 0.18958999, "shortRatio": 1.16, "shortPercentOfFloat": 0.052800003, "impliedSharesOutstanding": 54523200, "bookValue": -2.476, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -45753000, "trailingEps": -0.91, "forwardEps": -1.24, "enterpriseToEbitda": -3.834, "52WeekChange": -0.96768063, "SandP52WeekChange": 0.26238096, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "GRTX", "underlyingSymbol": "GRTX", "shortName": "Galera Therapeutics, Inc.", "longName": "Galera Therapeutics, Inc.", "firstTradeDateEpochUtc": 1573137000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "9ff241d9-e75a-35e9-b4be-f64d9dbab88e", "messageBoardId": "finmb_225098093", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.084, "recommendationMean": 3.0, "recommendationKey": "hold", "totalCash": 13466000, "totalCashPerShare": 0.248, "ebitda": -37399000, "totalDebt": 152262000, "quickRatio": 6.69, "currentRatio": 7.544, "returnOnAssets": -0.59294, "freeCashflow": -29474750, "operatingCashflow": -37973000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-24"}]